APOC2 and chronic kidney disease: In agreement with a previous study using an iTRAQ-based proteomic approach to identify apolipoproteins and proteins involved in lipid metabolism related to CVD in adult CKD patients (31), our proteomic approach identified apoC-II and apoC-III and found that they might be linked to CVD risk markers in pediatric CKD.